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Robert A. Rissman4, Eliezer Masliah4,5 and Lennart Mucke1,2*
Abstract
The maintenance of genomic integrity is essential for normal cellular functions. However, it is difficult to maintain
over a lifetime in postmitotic cells such as neurons, in which DNA damage increases with age and is exacerbated
by multiple neurological disorders, including Alzheimer’s disease (AD). Here we used immunohistochemical staining
to detect DNA double strand breaks (DSBs), the most severe form of DNA damage, in postmortem brain tissues from
patients with mild cognitive impairment (MCI) or AD and from cognitively unimpaired controls. Immunostaining for
γH2AX—a post-translational histone modification that is widely used as a marker of DSBs—revealed increased
proportions of γH2AX-labeled neurons and astrocytes in the hippocampus and frontal cortex of MCI and AD patients,
as compared to age-matched controls. In contrast to the focal pattern associated with DSBs, some neurons and glia in
humans and mice showed diffuse pan-nuclear patterns of γH2AX immunoreactivity. In mouse brains and primary
neuronal cultures, such pan-nuclear γH2AX labeling could be elicited by increasing neuronal activity. To assess whether
pan-nuclear γH2AX represents DSBs, we used a recently developed technology, DNA damage in situ ligation followed
by proximity ligation assay, to detect close associations between γH2AX sites and free DSB ends. This assay revealed no
evidence of DSBs in neurons or astrocytes with prominent pan-nuclear γH2AX labeling. These findings suggest that
focal, but not pan-nuclear, increases in γH2AX immunoreactivity are associated with DSBs in brain tissue and that these
distinct patterns of γH2AX formation may have different causes and consequences. We conclude that AD is associated
with an accumulation of DSBs in vulnerable neuronal and glial cell populations from early stages onward. Because of
the severe adverse effects this type of DNA damage can have on gene expression, chromatin stability and cellular
functions, DSBs could be an important causal driver of neurodegeneration and cognitive decline in this disease.
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Introduction
Genomic integrity is necessary for normal gene expression
and cellular functions. However, all cells in the body are
continually subjected to DNA damage from endogenous
and exogenous sources [16, 53, 65]. The cellular DNA
repair machinery evolved to reverse this damage. None-
theless, aging is associated with the accumulation of DNA
damage across diverse cell types, tissues and animal
species, and much evidence suggests that DNA damage
accelerates aging and related impairments [55, 57, 71, 83].
The ability to maintain genomic integrity is probably
most important for postmitotic cells that are long lived
such as neurons. Unable to divide, and for the most part
irreplaceable, the majority of neurons have to rely on
their genetic material for the lifetime of an organism.
Furthermore, neurons have a highly active metabolism
and produce large quantities of free radicals, which can
cause oxidative DNA damage [25]. Notably, increased
levels of DNA damage in aging brains are associated
with the reduced expression of essential genes, including
genes involved in neuronal plasticity [62]. Neuronal
DNA damage is further exacerbated in many neuro-
degenerative disorders [6, 42, 65, 92], which may contri-
bute to the extensive changes in gene expression and
neuronal loss found in these conditions.
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Numerous studies have reported increased evidence for
oxidative DNA damage in the brains, cerebrospinal fluid,
and peripheral cells of patients with mild cognitive impair-
ment (MCI) or Alzheimer’s disease (AD) [6, 22, 31, 58–60,
115]. This DNA damage has been attributed to increased
production of free radicals and to deficits in relevant DNA
repair pathways [8, 58]. Most often, oxidative DNA
damage appears to consist primarily of DNA base modi-
fications and single strand breaks [12, 27].
Interestingly, much less is known about the association
between AD and DNA double strand breaks (DSBs), the
most deleterious form of DNA damage. In dividing cells,
unrepaired DSBs can lead to cell cycle arrest and cell
death [120], while the inaccurate repair of DSBs can lead
to mutations, deletions, or chromosomal translocations
[20, 110]. Unlike dividing cells, which can utilize sister
chromatids to repair DSBs in an error-free manner by
homologous recombination, postmitotic neurons must
resort to more error-prone mechanisms of DSB repair
such as nonhomologous end joining (NHEJ) [39, 51].
Thus, DSBs could be particularly detrimental to neuronal
function and survival, and thereby promote the develop-
ment of age-related cognitive decline or disease [65].
The response to DSB formation involves the rapid
post-translational modification and recruitment of mul-
tiple proteins to broken DNA ends and the surrounding
chromatin. One of the earliest events in this process is
the phosphorylation of the histone variant H2AX at
serine 139, which occurs at multiple sites for up to
megabases of chromatin surrounding the break site
[5, 35, 91, 99]. Nuclear foci containing high concen-
trations of phospho-S139-H2AX, termed γH2AX, can be
visualized by immunohistochemistry and are widely used
as putative evidence for the presence of DSBs [54, 91].
Many DSB response proteins, including 53BP1, are also
recruited to and retained at sites of DSBs at high concen-
trations and can be visualized with similar methods.
Current reports of DSBs in the brains of patients with
AD are conflicting. One population-based study demon-
strated γH2AX immunoreactivity in neurons and glia of
patients with low levels of AD pathology and suggested a
trend toward decreasing γH2AX levels as AD pathology
increased [100]. The same group showed that γH2AX
immunoreactivity could be detected in brain cells of aged
people with little or no AD pathology, and that the
number of γH2AX-positive neurons inversely correlated
with bedside cognitive test scores [101]. In contrast,
another group found evidence for γH2AX immuno-
reactivity in astrocytes, but not neurons, in brains from
patients with advanced AD pathology [76].
Notably, these studies used immunoperoxidase staining
to detect γH2AX and showed diffuse, pan-nuclear staining
patterns, as opposed to the focal pattern seen at genuine
DSBs [54, 90]. More recently, Mano and colleagues
complemented γH2AX immunoperoxidase staining with
the neutral comet assay [79, 80, 102] to demonstrate
increased levels of DSBs in a small number of AD patients
[68]. However, the neutral comet assay does not allow for
a determination of the cell types that harbor DSBs, can be
confounded by topological changes in DNA induced by
experimental conditions [3], and relies solely on the pre-
sence of broken DNA strands, some of which might result
from postmortem tissue degradation.
In this study, we used the well-established neutral
comet assay, as well as optimized immunohistochemical
approaches, novel technologies and high-resolution
microscopy on postmortem brain tissues from two in-
dependent human cohorts to determine whether AD
and MCI, a frequent harbinger of AD [46, 67], are asso-
ciated with an increase in neuronal DSBs. We used
mouse and cell culture models to validate our DSB de-
tection methods and to differentiate cellular staining
patterns that represent DSBs from those caused by other
processes that could confound the interpretation of
results obtained by widely used methods.
Materials and methods
Human postmortem tissues and neuropathological
diagnosis
Cohort 1 consisted of 13 cases (Additional file 1: Table S1).
Tissues were obtained from the University of California,
San Francisco (UCSF) Neurodegenerative Diseases Brain
Bank. Before their death, subjects had been studied neuro-
logically and psychometrically at the UCSF Memory and
Aging Center. Authorization for autopsy was provided by
all subjects or their next-of-kin in accordance with the
Declaration of Helsinki, and all procedures were approved
by the UCSF Committee on Human Research. At autopsy,
the cerebrum was cut fresh into 1 cm thick coronal slices
and fixed for 48–72 h in buffered 10% formalin. Neuro-
pathological diagnoses were made in accordance with con-
sensus diagnostic criteria [33, 70] using histological and
immunohistochemical methods as described [108]. Cases
were selected based on neuropathological diagnosis. Blocks
of the inferior frontal gyrus, pars orbitalis were dissected
and placed into PBS with 0.02% sodium azide for storage.
Cohort 2 consisted of 23 cases (Additional file 1: Table S2).
Before their death, subjects had been examined neurologic-
ally and psychometrically at the Shiley-Marcos Alzheimer’s
Disease Research Center/University of California at San
Diego (ADRC/UCSD). Authorization for autopsy was
provided by all subjects or their next-of-kin in accor-
dance with the Declaration of Helsinki, and all pro-
cedures were approved by the UCSD Institutional
Review Board. At autopsy, brains were processed and
evaluated as described [87]. They were divided sagittally.
The left hemibrain was fixed in buffered 10% formalin or
4% paraformaldehyde (PFA) for 2 weeks for
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histopathological analysis; the right hemibrain was frozen
at − 70 °C for DNA damage in situ ligation followed by
proximity ligation assay (DI-PLA). Paraffin sections of
formalin-fixed neocortical, limbic and other subcortical
tissues were stained with hematoxylin and eosin (H&E),
or with antibodies against amyloid-β (Aβ) or phosphory-
lated tau (Additional file 1: Table S3), followed by de-
tection of primary antibodies with species-matched
secondary antibodies (Agilent/Dako), development
with the immunoperoxidase method, and visualization
by light microscopy as described [87]. Neuropatho-
logical analysis included counting of amyloid plaques
and neurofibrillary tangles (per 0.1 mm2), and Braak sta-
ging [33, 87].
Double-immunolabeling and laser scanning confocal
microscopy of human brain sections
For Cohort 1, double-immunolabeling studies were per-
formed on free-floating 30-μm microtome sections from
the orbitofrontal cortex. Briefly, sections were washed in
Tris-buffered saline (TBS), permeabilized in TBS contain-
ing 0.5% Triton X-100 (Sigma-Aldrich) at 4 °C overnight,
and incubated for 15min at 110 °C in citrate buffer (pH
6.0) for antigen retrieval. They were then incubated in 3%
H2O2 and 10% methanol for 15min, 0.1% Sudan Black
(Sigma-Aldrich) in 70% ethanol for 15min, and 10% goat
serum in TBS containing 0.1% Tween-20 (TBST) for 1 h.
Anti-γH2AX and anti-NeuN antibodies (Additional file 1:
Table S3) in TBST containing 3% goat serum were applied
first at 4 °C overnight and then at room temperature
for 2 h. Primary antibodies were detected with Alexa
Fluor secondary antibodies (Thermo Fisher Scientific) at
1:500 dilution. All sections were processed simultaneously
under the same conditions, except that for some sections,
TO-PRO-3 (Thermo Fisher Scientific) was used to stain
nuclei. Sections were mounted onto glass slides and cov-
ered with ProLong Diamond Antifade Mountant (Thermo
Fisher Scientific).
Confocal images were acquired from cortical layer II/III
with an LSM 880 laser-scanning confocal microscope
(Zeiss, Germany) and a 20x objective lens (NA 0.8).
Z-stack images were taken with sequential acquisition
settings at pixel size of 0.41 μm. ImageJ software [93] was
used to analyze γH2AX foci. First, the NeuN channel was
used to select 50 neurons from a single image per case. In
these cells, the γH2AX channel was then used to calculate
the number of γH2AX foci per nucleus through manual
counting. The proportion of neurons with one or more
γH2AX foci was calculated. Neurons with pan-nuclear
γH2AX signals were excluded from the analysis.
For Cohort 2, double-immunolabeling studies were per-
formed on free-floating 40-μm vibratome sections from
the mid-frontal cortex (Brodmann area 46) and hippo-
campus as described [87]. Briefly, sections were washed
with phosphate-buffered saline (PBS), permeabilized for
20min in PBS containing 1% Triton X-100 (Sigma-Al-
drich), and blocked with 10% horse serum in PBS for 1 h
at room temperature. Sections were then incubated at 4 °
C overnight with primary antibodies against γH2AX or
53BP1 in combination with antibodies against NeuN or
GFAP (Additional file 1: Table S3). Fluorescein isothio-
cyanate (FITC)-conjugated secondary antibodies (1:75,
Vector Laboratories) were used to detect anti-γH2AX, in
which case anti-NeuN and anti-GFAP were detected with
the Tyramide Signal Amplification (TSA) Direct (Red) sys-
tem (NEN Life Sciences, Boston, MA). Anti-53BP1 was
detected with the tyramide red system, in which case
FITC-coupled secondary antibodies were used to de-
tect anti-NeuN and anti GFAP. For the TSA step, horse-
radish peroxidase (HRP)-coupled secondary antibody was
used at 1:500 for 30 min, and TSA working solution was
used at 1:100 for 10 min. Negative controls included the
omission of each primary antibody. Sections from the
mid-frontal cortex and hippocampus (one each per case)
were processed simultaneously under the same condi-
tions, and experiments were performed twice. For some
sections, Hoechst 33342 was used to stain nuclei. Sec-
tions were mounted onto Superfrost Plus slides
(Fisher) and covered with ProLong Gold Antifade
Mountant (Thermo Fisher Scientific).
Confocal images were acquired with a Radiance 2000
laser scanning confocal microscope (Bio-Rad, Hercules,
CA) equipped with an Eclipse E600FN microscope
(Nikon, Japan) and a Nikon Plan Apo 60x oil objective
(NA 1.4; oil immersion). Two sections were analyzed per
case. From each double-labeled section, a total of 10
images (1024 × 1024 pixels, final magnification 630x)
were obtained from the mid-frontal cortex (layers 2–3)
and hippocampus (CA1, CA3 and dentate gyrus) and
analyzed using the ImageJ program [93] as described [87]
to determine the proportion of NeuN- or GFAP-positive
cells with γH2AX foci or 53BP1 labeling.
Immunoperoxidase staining to assess AD pathology,
calbindin and 53BP1 in human brain sections
For Cohort 2, free-floating 40-μm vibratome sections from
the mid-frontal cortex (Brodmann area 46) and anterior
hippocampus were washed with TBS, pre-treated in 3%
H2O2, and blocked with 10% serum (Vector Laboratories,
Burlingame, CA), 3% bovine serum albumin (Sigma-Al-
drich), and 0.2% gelatin in TBST. Sections were incubated
at 4 °C overnight with the following primary antibodies:
anti-Aβ, anti-phosphorylated tau, anti-calbindin, or
anti-53BP1 (Additional file 1: Table S3). Sections were
then incubated in secondary antibodies (1:75, Vector
Laboratories), followed by HRP-labeled Avidin D
(ABC Elite, Vector Laboratories), and reacted with di-
aminobenzidine (DAB, 0.2 mg/ml) in 50mM Tris (pH 7.4)
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and 0.001% H2O2. Control experiments included replace-
ment of primary antibodies with pre-immune rabbit
serum or non-immune IgG1, and preadsorption of the
anti-53BP1 antibody at 4 °C overnight with a 20:1 excess
of a synthetic 53BP1 peptide (Abcam, ab98293) designed
to block activity of this antibody, followed by centrifuga-
tion at 5000 x g for 10min and application of the super-
natant to sections.
Immunostained sections were imaged with a BX50
digital microscope (Olympus). Aβ deposits and intra-
neuronal accumulations of phosphorylated tau were
quantified as described [87]. Levels of calbindin and
53BP1 immunoreactivity were quantified using the
Image-Pro Plus program (Media Cybernetics, Silver
Spring, MD). For each case, 2 sections and 10 digital
images per section (at 400x) were analyzed to estimate the
average intensity of calbindin immunostaining (corrected
optical density) in the dentate gyrus and the average
number of 53BP1-immunoreactive cells per 0.1 mm2 in
the mid-frontal cortex.
Mice and treatments
Male and female C57Bl/6 J mice were maintained on a
12 h light/dark cycle. Experiments were conducted during
the light cycle. Mice had free access to food (PicoLab
Rodent Diet 20, LabDiet) and water and were housed 2–5
per cage. All studies were approved by the UCSF Institu-
tional Animal Care and Use Committee and were consis-
tent with NIH guidelines. All mice used were wildtype.
Some mice were exposed once to whole body ionizing
radiation (4 or 8 Gy) from a Mark-I Cesium137 source
(JL Shepherd and Associates, San Fernando, CA) in a
partitioned clear plastic chamber on a rotating platform.
The exposure took 1.16–3.32min and mice were killed
between 15 and 120 min after irradiation as indicated in
figure legends.
Unless indicated otherwise, mice were killed following
anesthesia with Avertin (tribromoethanol, 250mg/kg) by
transcardial perfusion with 0.9% NaCl. Brains were
dissected, divided along the sagittal midline, and hemi-
brains were frozen on dry ice in cryovials (Wheaton) or
fixed in 4% paraformaldehyde in PBS.
For treatment with kainate alone, kainate was dissolved
in 0.9% saline to a concentration of 4mg/ml. Some mice
received a single intraperitoneal injection of kainate (20 or
30mg/kg body weight) or saline. One hour after the injec-
tion, mice were anesthetized with Avertin (tribromoethanol,
250mg/kg) and perfused transcardially with 0.9% NaCl.
For use in combination with irradiation experiments,
kainate was dissolved in 0.9% saline to a concentration
of 2 mg/ml. All mice received a single intraperitoneal
(i.p.) injection of kainate (20 mg/kg body weight) or
saline. Some of the mice were then placed into a parti-
tioned clear plastic chamber and received 8 Gy whole
body ionizing radiation 15 min after the i.p. injection.
They were killed 60 min after the irradiation. Non-ir-
radiated mice were killed 75 min after the i.p. injec-
tion. All mice injected with kainate displayed signs of
epileptic activity ranging from rhythmic mouth and
facial movements to full motor seizures with loss of
postural control.
Immunohistochemical analysis of mouse brain tissues
Hemibrains were drop-fixed with 4% paraformaldehyde
in PBS for 48 h at 4 °C, washed in PBS, and infiltrated
with 30% sucrose in PBS until hemibrains sank (≥ 12 h).
Hemibrains were then cut into 30 μm sections with a
SM200R sliding microtome (Leica). Sections were stored
at − 20 °C in a solution of 40% PBS, 30% glycerol and
30% ethylene glycol until further use.
For fluorescence immunohistochemistry, sections were
washed in TBS, permeabilized in TBS with 0.5% Triton
X-100 (Sigma-Aldrich), and incubated for 15min at 110 °
C in citrate buffer (pH 6.0) for antigen retrieval. After in-
cubating sections for 15min in 3% H2O2 and 10% metha-
nol, sections were blocked in 10% goat serum in TBS for
1 h and then incubated overnight at 4 °C with antibodies
against parvalbumin, γH2AX, NeuN, or 53BP1 (Add-
itional file 1: Table S3) in 3% goat serum in TBS with gen-
tle rocking. The next day, sections were rocked at room
temperature for 2 h, washed in TBS with 0.1% Tween and
incubated for 2 h at room temperature with Alexa Fluor
secondary antibodies (Thermo Fisher Scientific) at 1:500–
1:2000 dilution in TBS with 3% goat serum. Sections were
mounted onto glass slides and covered with ProLong Dia-
mond Antifade Mountant (Thermo Fisher Scientific).
Confocal images were acquired from hippocampal CA1
or dentate gyrus with an LSM 880 confocal laser scanning
microscope (Zeiss) and a 20x objective lens (NA 0.8).
Z-stack images were taken with sequential acquisition set-
tings at pixel size of 1.66 μm for low-magnification images
and 0.21 or 0.41 μm for high-magnification images. Max-
imum intensity projections were created for all images.
Images of the entire dentate gyrus were stitched together
using ZEN software (Zeiss). Images acquired from two
coronal sections per mouse were analyzed. Briefly, the
dentate gyrus and a background area containing no cells
were manually traced as regions of interest. After subtract-
ing the γH2AX fluorescence intensity of the background
region from the fluorescence intensity in the dentate
gyrus, the fluorescence intensity in kainate-injected mice
was normalized to that in saline-injected mice.
DI-PLA on mouse brain sections
Snap-frozen mouse hemibrains were embedded in O.C.T.
compound (Tissue-Tek), cryosectioned at 10 μm, mounted
on Superfrost Plus Gold slides (Thermo Fisher Scientific),
and stored at − 80 °C until use. Using the Duolink PLA
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Orange detection reagent (Sigma-Aldrich) per manufac-
turer’s instructions, the DI-PLA was then carried out as
described [23] with the following modifications. Before
blunting DSB ends, endogenous biotin was blocked with a
biotin blocking kit (Molecular Probes) per manufacturer’s
instructions. Ligation of the biotinylated linker was carried
out for 1 h at room temperature as opposed to over-
night at 16 °C. Sections were incubated in anti-γH2AX
and anti-biotin antibodies in PBS with 0.1% Tween and
5% goat serum overnight at 4 °C. After completion of
PLA chemistry per manufacturer’s instructions, sections
were incubated with anti-NeuN antibody in PBS with
0.1% Tween and 5% goat serum for 0.5–1.0 h at room
temperature. Sections were then incubated with Alexa
Fluor-conjugated secondary antibodies (Thermo Fisher
Scientific; 1:1000) in PBS with 0.1% Tween and 5% goat
serum for 1 h at room temperature to visualize NeuN in
addition to the PLA signal. Sections were then washed in
PBS with 0.1% Tween and then with PLA wash buffers A
and B, prepared per manufacturer’s protocols. After com-
pletion of the DI-PLA protocol, sections were allowed to
air dry at room temperature while protected from light.
They were then covered with ProLong Diamond Antifade
Mountant (Thermo Fisher Scientific).
Slides were imaged with a Zeiss LSM 880 confocal
microscope and a 20X objective (NA 0.8). Z-stack
images were taken with sequential acquisition settings at
pixel sizes of 0.15–0.41 μm. Maximum intensity projec-
tions were created for all images. As specified in figure
legends, 3–4 images of the somatosensory cortex or
dentate gyrus were obtained from each of two sections
per mouse. For negative control sections, 2–3 images
were obtained from a single section per mouse.
Images were analyzed using ImageJ [93] and a macro de-
veloped in-house. Briefly, maximum intensity projections
were background subtracted, the NeuN channel was then
thresholded and smoothed, and neuronal nuclei were identi-
fied and assigned as regions of interest (ROI) using the
“analyze particles” function. The “find maxima” function
was then used on the corresponding DI-PLA channel to
automatically count the number of DI-PLA foci in the de-
fined ROI. For cortical sections, the number of DI-PLA foci
per neuron was calculated; for dentate gyrus sections, the
number of DI-PLA foci per 100 μm2 neuronal area was cal-
culated. A background noise tolerance was set by the experi-
menter to ensure only DI-PLA foci were detected as
“maxima.” For any given experiment, all user-defined vari-
ables were kept constant across all images. Calculations
were processed using Python scripts developed in-house.
Generation, treatment and immunocytochemistry of
primary neuronal cultures
Primary hippocampal neuronal cultures were established
from individual day-0 C57Bl/6 J mouse pups as described
[75]. Cells were cultured on poly-D-lysine-coated 96-well
plates (Greiner; 20 wells/pup) in 100 μl Neurobasal
medium (Thermo Fisher Scientific) supplemented with
2% B27 (Thermo Fisher Scientific), penicillin/strepto-
mycin, and 1x GlutaMAX Supplement (Thermo Fisher
Scientific). On days in vitro (DIV) 7, 100 μl of fresh
medium was added to the conditioned medium in
each well.
At DIV 14, cultures were pretreated for 1 h with fully
conditioned medium containing vehicle or 1 μM tetro-
dotoxin (TTX) and then treated for 1 h with the same
conditioned medium containing vehicle or bicuculline
(10 μM). Cultures were then fixed with 4% paraformal-
dehyde in PBS for 15 min.
Fixed neuronal cultures were permeabilized in PBS
with 0.2% Triton X-100 (Sigma-Aldrich) for 5 min,
blocked in 10% goat serum in PBS for 1 h, and incubated
with anti-γH2AX (1:1000) and anti-NeuN (1:4000) anti-
bodies in 2% goat serum for 1.5 h at room temperature.
After 5 brief washes in PBS, cultures were incubated
with Alexa-Fluor conjugated secondary antibodies (1:2000,
Thermo Fisher Scientific) and Hoechst 33342 (5 μM) in
PBS with 2% goat serum for 1 h at room temperature.
After 5 more brief washes in PBS, cultures were kept in
PBS at 4 °C until imaging.
Immunostained cultures were imaged with a high-con-
tent ArrayScan system (Thermo Fisher Scientific) and a
40x objective, yielding 1024 × 1024 pixels per image. For
each well, 15–20 images were obtained from different areas.
For the γH2AX channel, maximum intensity projections
were calculated from 4 images taken at 1 μm intervals
along the z-axis (2 above and 2 below the focal
plane). For all other channels, a single z-plane was
imaged. ArrayScan software was used for image ana-
lysis. Briefly, the Hoechst 33342 channel was used to
define nuclei as regions of interest and intensity
values were calculated within those nuclei for each
channel. An average nuclear γH2AX intensity was cal-
culated for NeuN-positive cells. The median γH2AX
intensity for all neurons in a well was calculated. For
each independent neuronal culture, all wells of com-
parable conditions were treated as technical replicates.
The means of technical replicates were then calculated
and independent cultures were used as biological repli-
cates for statistical analyses.
Comet assay (single cell gel electrophoresis)
Primary hippocampal neuronal cultures were treated
with bicuculline (5 μM), etoposide (10 μM) or vehicle for
1 h at DIV 14. Cultures were rinsed once with cold
Ca2+ and Mg2+-free PBS, collected by gentle scraping,
spun down, and mixed with low-melting point agarose
(Trevigen). 50 μl of the mixture was applied onto each
CometSlide (Trevigen) and allowed to solidify at 4 °C for
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30 min. Lysis and comet assay were performed ac-
cording to instructions provided with the CometAssay
kit (Trevigen) with minor modifications. Briefly, cells
were lysed for 30 min at 4 °C, immersed in 1x TBE
buffer for 15 min, and electrophoresis was performed
at neutral pH at 1 V/cm (measured electrode to elec-
trode) for 30 min. Slides were immersed in dH2O for
5 min, 70% ethanol for 5 min, and dried at room
temperature overnight. Samples were then stained
with SYBR Green and imaged with a Zeiss LSM 880
microscope and a Fluar 5X objective (NA 0.25). DNA
damage was assessed by measuring comet tail length
using OpenComet software (v1.3.1). Experiments were
performed in three independent cultures established
from different mice. A total of 150–200 nuclei were
measured for each mouse and treatment condition.
Statistical analysis
Biological units were randomized during assays, imaging
and analyses. All images for a given experiment were
acquired using the same acquisition parameters. Wherever
possible, investigators were blinded during image acquisi-
tion and quantitations to clinicopathologic group of
humans and to treatment of mice. After acquisition, im-
ages for a given experiment were randomized and
renamed using a custom MATLAB (MathWorks) script.
Data were formatted and processed in Excel (Microsoft),
MATLAB (MathWorks) or Python. Statistical analyses
were carried out in Prism (GraphPad). For hypothesis test-
ing, data were first tested for normality using the
Shapiro-Wilk test. For normally distributed data, unpaired
two-tailed Student’s t-tests were used to compare two
groups, and one-way or two-way ANOVA with
Holm-Sidak post-hoc tests to compare three or more
groups. For data that were not normally distributed, we
used the Mann-Whitney U test to compare two groups
and the Kruskal-Wallis test and Holm-Sidak post-hoc
tests to compare three or more groups. The null hypo-
thesis postulated no difference between groups and was
rejected at P < 0.05. Quantitative data are presented as
means ± SEM.
Results
AD and MCI are associated with an accumulation of
γH2AX foci in nuclei of neurons and astrocytes
To explore whether AD is associated with evidence for
excessive neuronal DSBs, we first obtained postmortem
brain tissues from a relatively small pilot cohort
(Additional file 1: Table S1) and co-labeled sections
of the orbitofrontal cortex with antibodies against
γH2AX and the postmitotic neuronal marker NeuN.
In this cohort, we detected a trend towards increased pro-
portions of neurons with γH2AX foci and an increased
number of γH2AX foci per neuron in AD and mild
cognitive impairment (MCI) cases as compared to
cases without cognitive impairment (Additional file 1:
Figures S1 and S2a). Consistent with a previous re-
port [76], several AD cases and one MCI case had
high levels of γH2AX immunoreactivity in a propor-
tion of NeuN-negative cells (Additional file 1: Figure
S3 and data not shown), whereas the control cases
did not. However, this non-neuronal γH2AX immuno-
staining was pan-nuclear rather than focal and, thus,
may not represent DSBs (see below).
Based on these preliminary findings, we extended our
analysis to an independent, larger cohort of human cases
(Additional file 1: Table S2). We found that both AD
and MCI cases had twice as many neurons with γH2AX
foci in the frontal cortex than cognitively unimpaired
controls (Fig. 1a, b). The number of γH2AX foci per
neuron was also higher in AD and MCI cases than in
controls (Additional file 1: Figure S2b). Similar changes
were observed in the hippocampal CA1 region (Additional
file 1: Figure S4a).
AD and MCI cases showed comparable levels of neu-
rons with DSBs (Fig. 1a, b, Additional file 1: Figure S4a),
even though the accumulation of Aβ and phosphorylated
tau was much more extensive in AD than MCI brains
(Additional file 1: Figure S5). Interestingly, AD and MCI
cases showed comparable levels of calbindin depletion in
the dentate gyrus (Additional file 1: Figure S5), an
abnormality that likely reflects aberrant neural net-
work activity [81, 82], which has been implicated in
the generation of neuronal DSBs [64, 106].
In Cohort 2, we also examined GFAP-positive astrocytes
in greater detail. Compared to controls, AD and MCI
cases had an increased proportion of GFAP-positive astro-
cytes with γH2AX foci in the frontal cortex (Fig. 1c, d)
and CA1 region (Additional file 1: Figure S4b). Thus, our
data suggest that AD causes an accumulation of DSBs in
both neurons and astrocytes and that this process begins
at relatively early stages of disease progression.
AD and MCI are associated with neuronal increases and
astroglial decreases in pan-nuclear 53BP1 staining
Eliciting neuronal DSBs by irradiation or other means in
mice leads to the formation of distinct γH2AX foci in
brain cells that are co-labeled by antibodies to 53BP1
(Additional file 1: Figure S6 and ref. [106]), a protein
that is rapidly recruited to DSBs and has many putative
functions, including the promotion of DSB repair by the
non-homologous end-joining pathway [84]. To further
support our conclusion that the γH2AX foci we detected
in AD and MCI cases represent genuine DSBs, we
immunostained brain sections from Cohort 2 for this
additional DSB marker. AD and MCI cases showed
marked and comparable increases in the proportion of
neurons with nuclear 53BP1 staining in the frontal cortex
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and CA1 region (Fig. 2a, b, Additional file 1: Figure S4c).
However, in most neurons this 53BP1 staining was diffuse
and pan-nuclear rather than focal or punctate (Fig. 2a),
similar to what others have observed in neurons of deep
cerebellar nuclei from AD cases [10]. To ensure the target
specificity of this staining, we tested an independent
53BP1 antibody. It yielded a similar staining pattern,
which was eliminated by pre-adsorption of the antibody
with a peptide representing the 53BP1 immunogen
(Additional file 1: Figure S7).
To investigate whether the increased neuronal 53BP1
staining in AD and MCI cases might have emerged post-
mortem, we elicited neuronal DSBs in mice by irradi-
ation and drop-fixed their brains in 10% neutral buffered
formalin for 48 h either immediately after sacrifice or
after different postmortem intervals (PMI). Even after a
PMI of 9 h, irradiated mice showed marked increases in
crisp 53BP1 foci, which co-localized with γH2AX, rather
than pan-nuclear increases in diffuse 53BP1 staining
(Additional file 1: Figure S8). These results make it un-
likely that the increases in neuronal 53BP1 labeling we
and others [10] have detected in humans with AD or
MCI represent a postmortem artifact.
Surprisingly, AD and MCI cases had a lower propor-
tion of GFAP-positive astrocytes with pan-nuclear
53BP1 staining than controls (Fig. 2c, d, Additional file
1: Figure S4d). Although the processes that cause
AD-associated changes in 53BP1 expression remain to
be determined, our results make it likely that they affect
neurons and astrocytes differentially.
Pan-nuclear H2AX phosphorylation in neurons can be
caused by increases in neuronal activity but is unlikely to
represent DSBs
As described above, focal γH2AX immunoreactivity is a
well-established marked of DSBs. While measuring this
marker, we noticed that γH2AX immunostaining labels
the nuclei of some neurons diffusely, in humans as well
a b
c d
Fig. 1 Increased proportion of neurons and astrocytes with γH2AX foci in frontal cortex of cases with MCI or AD. Frontal cortex sections from
cognitively unimpaired controls (Ctl) and from MCI and AD cases were co-labeled for γH2AX (green) and for NeuN (red) (a, b) or the astroglial
marker GFAP (red) (c, d). Nuclei were stained with Hoechst 33342 (blue). a Representative confocal images of neuronal γH2AX staining. b Proportion
(%) of neurons with at least one γH2AX focus. c Representative confocal images of astroglial γH2AX staining. d Proportion (%) of astrocytes with at
least one γH2AX focus. n = 8 Ctl, 7 MCI, and 8 AD cases from Cohort 2. **p < 0.01, ****p < 0.0001 vs. Ctl by one-way ANOVA and Holm-Sidak test. Scale
bars: 10 μm. Bar graphs represent means ± SEM
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as mice (Fig. 3). In wildtype mice that were not exposed
to any experimental manipulation before death, a large
proportion of specific neuronal populations showed
prominent pan-nuclear γH2AX staining, for example,
≥30% of parvalbumin-positive interneurons in CA1 (Fig.
3b). These findings raise the intriguing possibility that
focal and pan-nuclear patterns of H2AX phosphoryl-
ation have different causes and consequences.
Because parvalbumin-positive interneurons are among
the fastest spiking neurons in the brain [32], we wondered
whether neuronal activity itself could increase pan-nuclear
γH2AX staining. To test this hypothesis, we injected mice
with the glutamate receptor agonist kainate to induce
epileptic activity. Within one hour after mice received an
intraperitoneal injection of kainate (20–30mg/kg body
weight), they all showed evidence of seizure activity
(data not shown). Compared to saline-injected con-
trols, kainate-injected mice showed a marked increase
in pan-nuclear neuronal γH2AX staining in the dentate
gyrus (Fig. 4a, b).
To further assess the relationship between neuronal ac-
tivity and pan-nuclear γH2AX staining, we increased the
activity of mouse neurons by treating primary cultures
with the GABAA receptor antagonist, bicuculline. This
treatment was well tolerated and did not cause overt
toxicity at the doses used here (data not shown). One
hour after bicuculline treatment, NeuN-positive neurons
showed a robust increase in γH2AX staining, which was
pan-nuclear rather than focal (Fig. 4c, d). Pre-treatment of
neuronal cultures with the sodium channel antagonist
tetrodotoxin (TTX) abolished the bicuculline-induced
increases in γH2AX staining, confirming that they were
indeed activity-dependent (Fig. 4c, d). Taken together,
these results suggest that high levels of neuronal activity
promote pan-nuclear H2AX phosphorylation in vitro and
in vivo, possibly without causing the formation of DSBs.
a b
c d
Fig. 2 Pan-nuclear 53BP1 staining is increased in neurons and decreased in astrocytes in frontal cortex of MCI and AD cases. Frontal cortex sections from
cognitively unimpaired controls (Ctl) and from MCI and AD cases were double-labeled for 53BP1 (green) and for NeuN (red) (a, b) or the astroglial
marker GFAP (red) (c, d). Nuclei were stained with Hoechst 33342 (blue). a Representative confocal images of neuronal 53BP1 staining. b Proportion (%)
of neurons with pan-nuclear 53BP1 staining. c Representative confocal images of astroglial 53BP1 staining. d Proportion (%) of astrocytes
with pan-nuclear 53BP1 staining. n = 8 Ctl, 7 MCI, and 8 AD cases from Cohort 2. ***p < 0.001, ****p < 0.0001 vs. Ctl by one-way ANOVA
and Holm-Sidak test. Scale bars: 10 μm. Bar graphs represent means ± SEM
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Comet assay and DI-PLA reveal no evidence for DSBs in
neurons with pan-nuclear H2AX phosphorylation
To determine whether pan-nuclear H2AX phospho-
rylation is associated with DSBs, we first performed the
comet assay in primary hippocampal cultures. Performed
at neutral pH, this assay mainly detects DSBs, the extent
of which is reflected by the length of comet tails that
emerge from cell nuclei upon electrophoresis [78]. The
mean comet tail length from bicuculline-treated samples
was not significantly different from mock-treated samples
(Fig. 5a, b), although bicuculline treatment induced pan-
nuclear γH2AX staining (Fig. 5c). Positive control samples
treated with the genotoxic agent etoposide showed in-
creased comet tail length and γH2AX foci (Fig. 5). These
results further support the notion that pan-nuclear
γH2AX formation can occur in the absence of DSBs.
The neutral comet assay does not determine the specific
cell types that harbor DSBs. To address this shortcoming
and to further differentiate between DSBs and pan-nuclear
γH2AX formation, we used the recently developed DNA
damage in situ ligation followed by proximity ligation assay
(DI-PLA) [23]. This assay (Fig. 6a) builds on the original
findings that double stranded linkers can be specifically li-
gated to free DSBs in situ [29] and that when such linkers
are biotinylated, DSB ends can be purified on streptavidin
beads [14]. To identify bona fide DSBs, Galbiati and
colleagues combined this biotinylated DSB linker
strategy with a proximity ligation assay that allows for
the visualization of chromatin sites at which free DSB
ends are located in close proximity to γH2AX [23].
We first confirmed that the DI-PLA readily detects
DSBs in the brains of mice that were exposed to
whole-body ionizing radiation (Fig. 6b). Following this
treatment, DI-PLA signals in neurons increased, peaking
at approximately 1 h after irradiation, and then decreased,
most likely as the result of DSB repair (Fig. 6c). Negative
controls included the omission of the biotinylated linker
and of primary or secondary antibodies (Fig. 6c).
To exclude the possibility that pan-nuclear γH2AX
staining simply obscures the presence of γH2AX foci
representing DSBs, we designed the experiment outlined
in Fig. 7a. To increase the number of neurons with
pan-nuclear γH2AX staining, mice received an intraperi-
toneal injection of kainate (20 mg/kg), or saline as a
negative control. To cause DSBs, roughly half of the
mice received 8 Gy of ionizing whole-body irradiation
shortly after the injection of kainate or saline. All mice were
then analyzed by immunohistochemistry and DI-PLA.
Kainate treatment increased the proportion of neurons with
pan-nuclear γH2AX staining in the dentate gyrus but did
a b
Fig. 3 Pan-nuclear H2AX phosphorylation in neurons of humans and mice. a Representative confocal microscopic images of sections from the orbitofrontal
cortex of an AD case from Cohort 1. Sections were immunostained for γH2AX (red) and NeuN (grey). Orange circles outline nuclei. Two distinct patterns of
γH2AX immunoreactivity were observed: foci (white arrows) and pan-nuclear (green arrows). Scale bar: 10μm. b Representative confocal images of sections
from the CA1 region of a mouse. Sections were immunostained for γH2AX (red) and parvalbumin (grey). Green arrows highlight the large proportion of
parvalbumin-positive interneurons showing pan-nuclear γH2AX labeling under physiological conditions. Scale bar: 50 μm
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not cause γH2AX foci, unless mice were also irradiated
(Fig. 7b, c). The dose of irradiation used here caused many
neuronal DSBs, which were readily detectable by γH2AX
staining and by DI-PLA independent of whether neurons
had kainate-induced increases in pan-nuclear γH2AX
staining or not (Fig. 7d, e). Thus, in the absence of
focal γH2AX staining, pan-nuclear γH2AX staining
should not be interpreted as evidence for DSBs and may
reflect increased levels of neuronal activity.
Lastly, we attempted to use the DI-PLA for the detection
of DSBs in human postmortem tissues. However, we ob-
served substantial signal variations when we analyzed sec-
tions from the same cases on different occasions (data not
shown). We did not find such variations in mice, in which
the DI-PLA yielded reliable results even when we simulated
human postmortem conditions (Additional file 1: Figure S9),
suggesting that the difference may be due to premortem
factors or other variables.
Discussion
Our results suggest that AD causes neuronal accumula-
tion of DSBs even at relatively early stages of the illness.
Because unrepaired DSBs can lead to cell death [4, 120],
neuronal DSB accumulation may contribute to neuro-
degeneration. DSBs can also cause changes in trans-
cription from gene promoters located near break sites
[36, 47, 85, 96], which could lead to changes in neuronal
and synaptic functions. Recent evidence suggests that
neuronal DSB formation could also provide entry
points for the retro-insertion of genomic complemen-
tary DNAs and give rise to mosaic mutations of the
APP gene in AD [49]. DSB-related changes in gene
expression may explain, at least in part, why some brain
regions that are relatively resistant to neuronal loss in
AD—for example, the dentate gyrus—still show molecular
and radiological alterations suggestive of major dysfunc-
tion [1, 2, 13, 81, 103].
a b
c d
Fig. 4 Increased neuronal activity causes pan-nuclear neuronal γH2AX labeling in vivo and in vitro. a, b Mice were analyzed 1 h after they received an
intraperitoneal injection of kainate (KA, 20 or 30mg/kg) or vehicle (saline) at 4–6months of age. a Representative confocal microscopic images of
dentate gyrus sections co-labeled for γH2AX (red) and NeuN (grey). Insets show higher magnification views of the areas outlined by yellow squares.
Note the pan-nuclear pattern of the γH2AX labeling. Scale bars: 200 μm; 10 μm (insets). b Quantitation of γH2AX immunofluorescence intensity in the
dentate gyrus. Mean levels in saline-treated mice were arbitrarily defined as 1.0. n = 9 mice per group (pooled from 3 independent experiments).
***p < 0.001 by Mann-Whitney test. c, d Primary hippocampal neuronal cultures from mice were pretreated for 1 h with vehicle or tetrodotoxin
(TTX, 1 μM) on DIV 14. Vehicle or bicuculline (Bic, 10 μM) was then added to the medium and cultures were incubated for 1 h. c Representative widefield
images of neuronal cultures co-labeled for γH2AX (red) and NeuN (grey). Scale bar: 10 μm. d Quantitation of neuronal γH2AX immunofluorescence
intensity. For each culture, the mean levels in different wells of saline-treated cultures were arbitrarily defined as 1.0. n = 4 independent cultures from
different mice per condition. *p < 0.05 vs. mean of 1.0 (control) by one sample t-test. Bars represent means ± SEM
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In dividing cell lines, some experimental conditions can
cause γH2AX foci without causing DSBs [43, 73, 88]. How-
ever, it is unclear how these findings relate to DNA damage
responses in the brain. In vivo, γH2AX foci appear to be
reliable indicators of true DSBs [54]. By immunostaining
for γH2AX foci in postmortem brain sections, we showed
that neuronal DSBs accumulate in MCI and AD to a
greater extent than in cognitively normal controls.
How does AD increase DSBs in neurons? During
normal aging, oxidative DNA damage accumulates in
the promoters of genes involved in learning and memory
and in neuronal survival [62]. AD further increases
oxidative damage in neurons [8, 59, 60, 69]. Oxidative
damage can result in DSBs, particularly when multiple
oxidative lesions occur close to one another [94, 97].
Therefore, excessive production and/or reduced inactiva-
tion of free radicals represent plausible mechanisms for
the accumulation of neuronal DSBs in AD. Other lines
of evidence suggest that aberrant neuronal activity can
increase neuronal DSBs independent of oxidative stress
[106] and that increased or excessive stimulation of
neuronal glutamate receptors can lead to DSB formation
within the promoters of early-response genes [64]. In
light of these studies, chronic network hyperexcitability,
which is prevalent in AD [30, 48, 82, 111, 112], might
also contribute to the accumulation of neuronal DSBs.
In line with this notion, we found reduced neuronal levels
of calbindin in the dentate gyrus of MCI and AD cases, a
reliable indicator of chronic network hyperexcitability and
excessive calcium influx [34, 72, 81]. However, acute
a
b c
Fig. 5 Neutral comet assay detects no DSBs in primary cultures with elevated neuronal activity and pan-nuclear γH2AX elevation. a–c Cultures of
primary hippocampal mouse neurons were assessed for DSB levels by the neutral comet assay (a, b) or immunocytochemistry (c). Cells were
treated with vehicle (Ctrl), 10 μM bicuculline (Bic) or 5 μM etoposide (ETP) for 1 h before harvesting. a Representative images of cell nuclei stained
with SYBR Green after electrophoresis at neutral pH. Insets show higher magnification views. Scale bar: 100 μm; 20 μm (insets). b Quantitation of
comet tail lengths. A total of 150–200 nuclei were measured for each mouse and condition. n = 3 cultures/mice per condition. Circles indicate
mean values for each mouse; grey dots indicate individual nuclei. ***p < 0.001 by one-way ANOVA and Holm-Sidak test. ns, not significant.
c Representative confocal images of cultured neurons exposed to the indicated treatments. Cells were co-labeled for γH2AX (green), NeuN
(red), and Hoechst 33342 (blue). Scale bar: 10 μm
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kainate-induced seizure activity in mice resulted in
pan-nuclear H2AX phosphorylation rather than DSB for-
mation. This finding casts doubt on the role of acute epi-
leptic activity as a potential cause of DSBs, although it
cannot exclude the possibility that chronic epileptic activ-
ity or other types of network dysfunction contribute to
DSB formation in AD and related conditions. Several re-
cent studies have demonstrated an increase in the level of
transposable elements in Alzheimer’s disease and other
neurodegenerative tauopathies [26, 107]. As some
transposons can cause DSBs through endogenous
endonuclease activity [24], their increase might also
contribute to the increase in DSBs we observed in MCI
and AD.
Interestingly, AD patients show evidence for DNA repair
deficits even in peripheral blood cells [11, 19] and several
proteins with known roles in DSB repair are depleted in
their brains [7, 41, 95, 98, 105]. Thus, deficits in DNA
repair may also contribute to the abnormal neuronal accu-
mulation of DSBs in AD. Several environmental factors,
including viruses and a high fat diet, have been linked to
the weakened DNA repair in AD. For example, several
c
ba
Fig. 6 DI-PLA detects DSBs in neurons of mice exposed to ionizing radiation. a Schematic of the DI-PLA. A biotinylated (green circle) linker (light
blue) is ligated to the free ends of a DSB (black lines). An antibody (black) against biotin and an antibody from a different species (dark blue)
against a DSB-associated repair factor (purple oval) are then added. Species-specific secondary antibodies (pink and orange) conjugated to DNA
oligonucleotides are used to detect the primary antibodies. If the primary antibody targets are located in close proximity, a connector oligonucleotide
ligates them to one another and allows for the creation of a closed circular DNA template that can be amplified by rolling circle amplification. Fluorescently
labeled oligonucleotides (red hexagons) hybridize to the amplicon and can be visualized by fluorescence microscopy. b Representative confocal images of
DI-PLA signals and NeuN immunostaining in somatosensory cortex sections from 3 to 6-month-old mice that were untreated (Home Cage, top) or exposed
to 8 Gy whole-body ionizing radiation 1 h before analysis (bottom). DI-PLA single channel (left) and merged views (right) are shown. Scale bar: 10 μm. c
Number of DI-PLA foci per neuron in somatosensory cortex from mice analyzed at different time points after 4 Gy or 8 Gy irradiation. Besides unirradiated
mice, negative controls included the omission of mouse (Ms) or rabbit (Rb) primary antibodies (1ry) and of mouse or rabbit secondary
antibodies (2ry). n = 4–5 mice per group. *p < 0.05 vs. Home Cage by one-way ANOVA and Holm-Sidak test. Bars represent means ± SEM
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studies have found increased evidence for the presence of
viral pathogens in AD brains, particularly herpes simplex
viruses (HSV) and human herpesvirus 6 (HHV6) [9, 37, 52,
61, 89]. Infection with HSV1 can cause DNA damage in
neurons, including DSBs [17], and impair DNA repair by
NHEJ [17, 50, 86]. A recent study found that a high fat diet
increased neuronal DSB levels and altered the balance of
DSB repair pathways in aged APP/PSEN1 mice [118]. It
a
b c
d e
Fig. 7 Experimental differentiation between focal and pan-nuclear neuronal γH2AX labeling. a Schematic of experimental design. Mice received
an intraperitoneal injection of kainate (KA, 20mg/kg) or saline (Sal) at 3–6months of age. Fifteen minutes later, roughly half of them were exposed to
8 Gy ionizing radiation (IR). One hour later, all mice were sacrificed and their brains processed for fluorescence immunohistochemistry (b, c) and DI-PLA
(d, e). b Representative confocal images of dentate gyrus sections co-labeled for γH2AX and NeuN. γH2AX single channel (left) and merged views
(right) are shown. Scale bar: 200 μm. c Representative higher magnification views of sections similar to those in (b). Scale bar: 10 μm. d Representative
confocal images from the apex of the dentate gyrus showing DI-PLA signals (left) and merged views with NeuN co-labeling (middle).
High-magnification images (right) show individual neurons with DI-PLA signals (green) and NeuN immunostaining (red). Scale bar: 50 μm
(left and middle), 10 μm (right). e Number of DI-PLA foci per 100 μm2 neuronal area in the apex of the dentate gyrus. n = 4–7 mice per
group. Two-way ANOVA revealed an effect of irradiation (p < 0.0001) but not of kainate (p = 0.8093) and no interaction between them
(p = 0.5201). **p < 0.01, ***p < 0.001 vs. Sal by Holm-Sidak test. Bars represent means ± SEM
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is tempting to speculate that this process may contri-
bute to the accelerated cognitive decline observed in
APP/PSEN1 mice on this diet [104, 109, 114].
Because 53BP1 promotes the repair of DNA damage,
including DSBs [38, 77, 116, 117], the absence of
53BP1-positive foci in neurons of MCI and AD cases
with clear evidence for DSBs by γH2AX immunostaining
in our study could, in principle, represent a DNA repair
deficit in AD. Specifically, recruitment of 53BP1 to DSBs
may be defective in AD. Such a recruitment defect
would be consistent with a recent report of decreased
53BP1 foci at DSBs in models of C9orf72 repeat expan-
sion, a common cause of amyotrophic lateral sclerosis and
frontotemporal lobar degeneration [113]. This decrease in
53BP1 foci was attributed, in part, to deficits in ubiquitin
signaling [113], which is required for the maintenance of
53BP1 at DSBs [15, 40, 63, 66]. Abnormalities in
ubiquitin-proteasome functions have also been detected
in brains of patients with AD [44, 45, 56], which may
explain why we did not find 53BP1 accumulation at DSBs
in this condition. However, γH2AX foci in neurons of
cognitively unimpaired controls also did not colocalize
with 53BP1 (data not shown). This finding raises the pos-
sibility that 53BP1 fulfills different functions in humans
than in mice, in which induction of DSBs consistently
resulted in the formation of nuclear foci containing both
γH2AX and 53BP1. It is unlikely that the absence of
53BP1 foci in human AD cases represents a postmortem
artifact, as neuronal 53BP1 foci could be readily identified
in brains of irradiated mice even after prolonged PMIs
and when using similar tissue fixation conditions as in the
human cases. It is also unlikely that AD depletes neuronal
53BP1 levels, as we found diffuse pan-nuclear increases in
53BP1 immunoreactivity in neurons of MCI and AD
cases, as compared to controls.
In the process of quantifying DSBs in MCI and AD,
we observed that γH2AX can also exist in a diffuse
pan-nuclear pattern in neurons that is distinct from its
focal accumulation at DSBs. We also found increases in
pan-nuclear γH2AX in non-neuronal cells in AD
brains, consistent with a previous report [76]. Similar
pan-nuclear increases in γH2AX formation have been
reported in the context of irradiation-induced apoptosis
in resting human lymphocytes [18], in response to
certain types of DNA damage in the absence of apop-
tosis in dividing cell lines and cultured primary cells
[28, 74], after cellular infection of dividing cell lines
with inactivated adeno-associated viral particles [21],
and after treatment with a high-dose alkylating agent in
a human amnion cell line [119].
Here, we were able to experimentally elicit pan-nuclear
increases in γH2AX immunoreactivity in vitro and in vivo
by increasing neuronal activity. In kainate-treated mice and
in cultured neurons treated with bicuculline, most neurons
with increased pan-nuclear γH2AX showed no evidence of
DSBs by DI-PLA or neutral comet assay, suggesting that
pan-nuclear and focal increases in γH2AX have different
causes and functions. In line with this conclusion, low doses
of the alkylating agent N-methyl-N′-nitro-N-nitroso-
guanidine (MNNG) caused the formation of γH2AX
foci and a positive neutral comet assay suggestive of
DSBs in a dividing cell line, whereas higher doses of
MNNG led to pan-nuclear H2AX phosphorylation with-
out evidence for DSBs by neutral comet assay [119].
Because we detected particularly high levels of pan-
nuclear γH2AX in fast-spiking interneurons at base-
line, it is tempting to speculate that high levels of
pan-nuclear γH2AX somehow support or result from
high levels of physiological neuronal activity in vivo.
Additional studies are needed to test these hypotheses and
to unravel the mechanisms involved. Notwithstanding
these uncertainties, our findings clearly demonstrate that
increases in overall levels of neuronal γH2AX—as
measured, for example, by western blot analysis—should
not be interpreted as evidence for DSB accumulation,
because such increases can result from changes in
neuronal activity, and possibly other processes, in the
absence of DSBs.
Conclusions
Our study demonstrates that DSBs accumulate in neurons
and astrocytes at early stages and during the progression
of AD, a process that may contribute to neuronal dysfunc-
tion and degeneration. Further investigation of the causes
and consequences of DSBs and other types of DNA
damage in AD and related conditions may identify
novel opportunities for therapeutic intervention.
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